The global Blood Collection Market was valued at USD 5.0 billion in 2025 and is projected to grow from USD 5.3 billion in 2026 to USD 8.2 billion by 2033, registering a CAGR of 6.3% from 2026 to 2033. The market continues to expand due to the rising volume of diagnostic procedures, increasing prevalence of chronic and infectious diseases, and growing demand for accurate laboratory testing across healthcare systems worldwide.

Blood collection remains a critical component of modern healthcare, supporting disease diagnosis, treatment monitoring, preventive screening, and clinical research. As healthcare providers increasingly emphasize early disease detection and personalized treatment strategies, the demand for reliable blood collection technologies continues to grow. Hospitals, diagnostic laboratories, clinics, and blood banks are investing in advanced collection systems that improve sample integrity, patient comfort, and testing accuracy.

The growing burden of chronic diseases such as diabetes, cardiovascular disorders, cancer, and kidney diseases is creating sustained demand for routine blood testing. In parallel, the continued monitoring of infectious diseases and public health threats has reinforced the importance of efficient blood collection infrastructure in supporting timely diagnosis and disease surveillance.

Rising Diagnostic Testing Driving Market Expansion

One of the primary factors fueling blood collection market growth is the increasing number of diagnostic tests performed globally. Blood samples remain the foundation of many laboratory analyses, enabling healthcare professionals to evaluate patient health, monitor disease progression, and assess treatment effectiveness.

Download a free sample copy of the Blood Collection Market report to understand detailed coverage and inclusions in the final report

Key diagnostic applications include:

• Disease screening and prevention
• Medication monitoring
• Cancer diagnostics
• Cardiovascular risk assessment
• Infectious disease detection
• Diabetes management
• Organ function evaluation
• Clinical research studies

The growing focus on preventive healthcare is encouraging regular health checkups and routine blood testing, particularly among aging populations and individuals at risk of chronic conditions. This trend continues to strengthen demand for blood collection devices, tubes, needles, and related consumables.

Importance of Sample Integrity and Transportation

Maintaining blood sample quality throughout collection, storage, and transportation remains a critical challenge for healthcare providers and laboratories.

Blood samples often require strict temperature control to preserve stability and prevent degradation. Improper handling can compromise diagnostic accuracy and potentially lead to incorrect treatment decisions. For example, inadequate temperature management during transportation may affect coagulation samples, resulting in inaccurate test outcomes and unnecessary medical interventions.

As healthcare systems increasingly rely on centralized laboratory networks and remote testing facilities, demand is rising for advanced blood collection solutions that support:

• Improved sample preservation
• Enhanced transportation safety
• Reduced contamination risks
• Better traceability and tracking
• Faster laboratory turnaround times

These requirements are driving innovation across blood collection technologies and logistics systems.

Key Market Trends & Insights

North America Dominates Global Market

North America accounted for 39.08% of global blood collection market revenue in 2025, making it the largest regional market.

The region benefits from:

• Advanced healthcare infrastructure
• High diagnostic testing volumes
• Strong adoption of laboratory technologies
• Growing prevalence of chronic diseases
• Significant healthcare spending
• Established reimbursement systems

The United States continues to lead regional growth due to increasing demand for diagnostic services, preventive healthcare initiatives, and expanding clinical laboratory networks.

Looking for more specific insights? Customize this report to suite your business needs

Venous Blood Collection Remains the Preferred Collection Site

• The venous segment held 81.66% of market share in 2025.
• Venous blood samples provide larger specimen volumes and support a broad range of laboratory tests.
• Rising incidence of chronic diseases has increased demand for comprehensive diagnostic evaluations requiring venous samples.
• Hospitals, diagnostic centers, and specialty clinics continue to rely heavily on venous collection procedures for accurate laboratory analysis.

Diagnostics Segment Leads Applications

• The diagnostics segment accounted for 83.36% of market share in 2025.
• Growing demand for rapid, accurate, and minimally invasive testing is supporting segment growth.
• Blood-based diagnostics remain essential for identifying infections, monitoring chronic diseases, and supporting personalized treatment plans.
• Increasing adoption of precision medicine and biomarker-based testing is further expanding diagnostic applications.

Manual Blood Collection Maintains Dominance

• The manual blood collection segment captured 81.73% of market share in 2025.
• Manual collection methods remain widely used due to their reliability, flexibility, and cost-effectiveness.
• Healthcare professionals prefer manual techniques when dealing with:
• Pediatric patients
• Elderly individuals
• Difficult vein access cases
• Specialized clinical procedures

Despite growing automation in laboratory environments, manual collection continues to represent the industry standard across many healthcare settings.

Hospitals Lead End-Use Demand

• The hospital segment held 39.12% of market share in 2025.
• Hospitals perform a high volume of diagnostic tests, emergency procedures, surgeries, and patient monitoring activities.
• Continuous patient inflow creates consistent demand for blood collection tubes, needles, lancets, and sample management systems.
• Increasing hospital investments in laboratory modernization are further supporting market growth.

Market Size & Forecast

• Market Size in 2025: USD 5.0 Billion
• Estimated Market Size in 2026: USD 5.3 Billion
• Projected Market Size by 2033: USD 8.2 Billion
• CAGR (2026–2033): 6.3%
• Largest Regional Market: North America
• Fastest-Growing Region: Asia Pacific

Emerging Trends Reshaping the Industry

Growth of At-Home Blood Collection

A significant emerging trend is the development of patient-centric blood collection technologies that enable remote and at-home sample collection.

Healthcare providers are increasingly embracing decentralized healthcare models, telehealth services, and home-based diagnostics. This shift has created demand for minimally invasive collection devices that allow patients to collect samples outside traditional healthcare facilities.

Explore Grand View Horizon to see global and regional level statistics related to the Blood Collection Market

Benefits include:

• Improved patient convenience
• Reduced healthcare facility visits
• Enhanced accessibility for rural populations
• Greater support for remote monitoring programs
• Lower healthcare delivery costs

Digital Healthcare Integration

The integration of blood collection systems with digital healthcare platforms is enhancing workflow efficiency and sample tracking. Advanced technologies now support:

• Barcode-enabled sample identification
• Electronic health record integration
• Automated specimen tracking
• Improved laboratory workflow management
• Enhanced data accuracy

These innovations are helping healthcare organizations reduce errors while improving patient outcomes.

Competitive Landscape

The blood collection market remains highly competitive, with established manufacturers focusing on innovation, product quality, and global expansion.

Leading companies continue investing in:

• Advanced blood collection devices
• Patient-friendly collection technologies
• Safety-engineered products
• Automated collection systems
• Decentralized diagnostic solutions
• Strategic partnerships and acquisitions

Emerging companies are introducing innovative solutions designed to improve patient comfort and support home-based diagnostics, creating new opportunities within the industry.

Key Blood Collection Companies

The following companies have been profiled in the global blood collection market:

• Abbott
• NIPRO Medical Corporation
• BD
• Terumo Corporation
• Medtronic
• QIAGEN
• FL Medical s.r.l.
• Greiner AG
• Haemonetics Corporation
• F. Hoffmann-La Roche Ltd.
• Sarstedt AG & Co. KG
• Centogene N.V.
• SEKISUI CHEMICAL CO., LTD.

Conclusion

The global blood collection market is experiencing steady growth driven by the increasing demand for diagnostic testing, rising prevalence of chronic and infectious diseases, and expanding healthcare access worldwide. As healthcare systems place greater emphasis on early diagnosis, preventive care, and personalized medicine, blood collection technologies remain essential to supporting accurate clinical decision-making.

Emerging innovations such as at-home blood collection devices, digital sample tracking, and decentralized diagnostic solutions are transforming traditional blood collection practices and improving patient convenience. With continued investments in healthcare infrastructure, laboratory modernization, and advanced collection technologies, the blood collection market is expected to maintain strong growth momentum through 2033.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments
• Extended forecast timelines for long-term planning
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…